Targets for cancer therapy in childhood sarcomas

Area of Science:

• Pediatric Oncology
• Cancer Therapeutics
• Molecular Targeted Therapy

Background:

• Chemotherapy has improved survival for many childhood cancers.
• Survival rates for rhabdomyosarcoma, osteosarcoma, and Ewing's sarcoma remain poor.
• Novel treatment strategies are critical for these aggressive pediatric sarcomas.

Purpose of the Study:

• To review potential therapeutic targets for childhood sarcomas.
• To explore advancements in targeted therapy for pediatric sarcomas.
• To identify promising targets for future clinical trials.

Main Methods:

• Comprehensive literature review of pre-clinical and clinical studies.
• Analysis of various molecular targets investigated for sarcoma treatment.
• Evaluation of therapeutic targets including receptor tyrosine kinases, signaling molecules, and sarcoma-specific fusion proteins.

Main Results:

• Numerous potential therapeutic targets have been identified.
• Targets include receptor tyrosine kinases, intracellular signaling pathways, cell cycle regulators, proteasome, heat shock protein 90 (hsp90), histone deacetylases, angiogenesis regulators, and fusion proteins.
• A wide array of targets indicates the complexity of pediatric sarcomas.

Conclusions:

• Targeted therapy holds promise for improving outcomes in pediatric sarcomas.
• The abundance of potential targets necessitates better pre-clinical model comparability.
• Prioritizing effective targets is crucial for successful clinical translation.